Bayer shares consolidate near €46 ahead of Q2 earnings, a $7.25B glyphosate settlement hearing, and new Trump tariff threats on generics, with analysts split on outlook. Bayer Faces a Pivotal August: ...
Bayer shares fall 2.1% as US court postpones Roundup settlement and analyst podcast flags poor returns and goodwill overhang. Bayer's Twin Headwinds: A Shifting Court Calendar and a Stinging Verdict ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results